| Tuberculous Scleritis | |
| This is a case of a 23 yrs old girl who had a recurrent painful scleritis left Eye,,which would respond to local steroids only to recurr after 2 weeks.Going on for nearly 6 months and she was having weight loss too.Later she developed a sclerocorneal infiltration and associated scleritis in the same upper temporal quadrant of the left eye.Her Mantoux test was strongly possitive.Haematological picture was not contributory except for marginal increase of ESR 18mm 1st hour. This time, based on the Mantoux reaction I put her on Rifampicin and INH (450mgms and 300 mgms orally) and no local medication.After the therapeutic trial of 21 days, the lesion regressed and subsequently ,the entire lesion regressed,she improved her general health, and gained weight.(from 45 Kgms to 50Kgms).She is totally symptom free till now for the last one year.She had the Anti Tb drug for 9 months. Retrospectively,this therapeutic trial confirms the diagnosis of Ocular tuberculosis which is often a hypersensitivity reaction to tubercular proteins,hiden hypothetically in some foci with in the body.The eye acts in the same way as a tubercular lymph gland behaves.In my practice I had very similar tubercular scleritis even earlier and without any local steroids( which is by and large the commonest form of RX for scleritis) the disease process regresses with anti Kochs treatment. The pictire shows active scleritis with limbalsclerokeratitis,strong mantoux possitive reaction, and a healed scar at limbus after 3 months of therapy. Regards, Dr.Rama Mohan Rao. Prof and HOD ,AJ Institute of Medical sciences,Mangalore | |
| Rao, Rama Mohan, Prof. Dr. med., India, Prof. Dr., Mangalore | |
| H19.0 | |
| Sclera -> Scleritis -> Anterior Scleritis | |
| 5932 |
|
||||||||||||
|
Tuberculous Scleritis-------------------------- -------------------------- -------------------------- -------------------------- -------------------------- -------------------------- -------------------------- -------------------------- -------------------------- -------------------------- -------------------------- -------------------------- |
|||||||||||